Quality By Design in Pharmaceutical Development: A Comprehensive Review of Concepts, Tools and Applications
Description
Quality by Design (QbD) has emerged as a transformative approach in pharmaceutical development, aiming to build quality into products from the earliest stages. Unlike traditional quality assurance methods that rely heavily on end-product testing, QbD emphasizes a thorough understanding of processes, identification of critical quality attributes (CQAs), and control strategies based on risk assessment and scientific rationale. This review explores the fundamental principles of QbD, its application across various stages of pharmaceutical development, and the regulatory framework supporting its implementation. Key components such as Design of Experiments (DoE), risk management tools, and the use of process analytical technology (PAT) are discussed in detail. The article also highlights the benefits and challenges of adopting QbD, including improved product consistency, regulatory flexibility, and resource optimization. Through this comprehensive overview, the review aims to provide insights into the evolving landscape of pharmaceutical quality management and the pivotal role of QbD in ensuring patient safety and product efficiency. Definition: Quality by Design (QbD) is a systematic approach to pharmaceutical development that emphasizes designing and building quality into a product from the beginning and process understanding and controls based on sound science Quality risk management (ICHQ8)